
EveryDay Health: How to talk to your family about your metastatic breast cancer diagnosis
The University of Cincinnati Cancer Center's Elizabeth Shaughnessy spoke with EveryDay Health about how to talk with family members following a metastatic breast cancer diagnosis.
Shaughnessy said it is helpful to write out some questions you think family may ask and their answers ahead of time.
“This can be very helpful,” said Shaughnessy, MD, PhD, director of survivorship and supportive services at the Cancer Center, adjunct professor and vice chair for patient experience in UC's College of Medicine. “It is a very emotional topic. Just the stress of having a conversation can cause the release of stress hormones, and this can make you forget what you wanted to say.”
It can also be helpful to suggest to partners or grown children that you need help, Shaughnessy said.
“You could say, ‘I will need help setting up and attending appointments and treatments, and it would also be helpful if someone could arrange for food and transportation for me,’” Shaughnessy said.
Read the EveryDay Health article.
Featured photo at top of pink Breast Cancer Awareness ribbon. Photo/Lludmila Chernetska/iStock.
Related Stories
Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
Wall Street Journal: More women with breast cancer could skip harsh radiation
February 16, 2023
The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.
MedPage Today: Promising results for living donor transplants
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.